$INTT

INTEST CORP (INTT): Submission of Matters to a Vote of Security Holders

INTEST CORP (INTT) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. intt-20260617 FALSE 0001036262 0001036262 2026-06-17 2026-06-17 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 17, 2026 Date of Report (Date of earliest ev

Original reporting
Published Jun 18, 2026, 8:26 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 18, 2026, 8:28 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$INTT
Neutral
high confidence
Mentioned
$INTT
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$INTTNeutralLow
01

Why it matters

The disclosure confirms director nominees were elected and that shareholders approved Amendment No. 1 to the 2023 Stock Incentive Plan, ratified the auditor (RSM US LLP), and approved the advisory compensation resolution.

02

Market read

This is a governance/administrative update with no new financial guidance or strategic transaction disclosed.

03

What to watch

Traders may still want to check whether any director election outcomes or plan amendments affect future compensation expense assumptions, but this 8-K does not include such forward-looking details.

Relevance 6/10Novelty 2/10Timing: filed after close on June 18, 2026 for the June 17 annual meeting

Background

The SEC 8-K (Item 5.07) summarizes matters voted on at InTest Corporation’s 2026 annual meeting of stockholders on June 17, 2026.

Company-level read

Ticker impact

$INTTNeutralHigh confidence
Context

InTest (INTT) filed an 8-K reporting June 17, 2026 annual meeting voting results for directors and key proposals.

Expected impact

Limited near-term impact; any reaction is likely confined to governance/plan housekeeping rather than fundamentals.

Evidence & confidence

The filing only reports outcomes of director elections and approvals (stock incentive plan amendment, auditor ratification, advisory say-on-executive compensation) without new financial metrics or strategic changes.

Market effects

None—this is company-specific governance voting disclosure.

None indicated.

None indicated.

Counterpoint

If the stock incentive plan amendment or say-on-pay vote was contentious, it could matter for longer-term governance sentiment, but the filing provides no dissent narrative or quantified implications beyond totals.

Key entities

  • InTest Corporation

    Subject of the 8-K; voting results for directors and corporate governance proposals.

  • RSM US LLP

    Ratified as independent registered public accounting firm for fiscal year ending Dec. 31, 2026.

Related articles

$INTTMedAI 8/10

InTest (INTT) Q2 2026 Earnings Call Transcript

InTest (INTT) reported Q2 2026 revenue of $35.3M, up 25.5% YoY, with semi orders $12.0M (+64% YoY) and backlog $45.4M (+19.8% YoY). Full-year guidance raised to $135M-$140M. Gross margin was 40.5% and adjusted EBITDA $2.2M. CFO cited a material weakness at Alfamation.

$INTTMed

INTEST CORP (INTT): Results of Operations and Financial Condition

INTEST CORP (INTT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 NEWS RELEASE 804 EAST GATE DRIVE, SUITE 200, MOUNT LAUREL, NJ 08054 FOR IMMEDIATE RELEASE InTest Reports Strong Second Quarter 2026 Revenue of $35.3 Million EPS of $0.04 and Adjusted EPS (Non-GAAP) of $0.09 • Second quarter revenue up 25.5% year-over-year, driven lar

$INTTMed

Why is inTest stock climbing today?

inTest Corp (INTT) shares rose 1.7% in pre-open trading after Northland upgraded the stock to “outperform” from “market perform” and set a $15.00 price target. Northland cited inTest’s preliminary Q2 2026 revenue estimate of about $35M and raised full-year 2026 revenue guidance to $135M-$140M, while noting a planned 220 bps gross margin reduction.

$INTTMed

INTEST CORP (INTT): Results of Operations and Financial Condition

INTEST CORP (INTT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 NEWS RELEASE 804 EAST GATE DRIVE, SUITE 200, MOUNT LAUREL, NJ 08054 FOR IMMEDIATE RELEASE InTest Reports Preliminary Second Quarter 2026 Results • Second Quarter Revenue Estimated to be Approximately $35 Million • Second Quarter Gross Margin Estimated to be Approxima

$ELVRMed

Elevra Lithium Ltd (ASX:ELV) Corporate Presentation - Outlines Growth Strategy for North American Lithium Platform

Elevra Lithium Ltd (ASX:ELV) outlined its growth strategy for North American Lithium (NAL) in Quebec, targeting 373,000 tonnes of spodumene concentrate annually. FY26 production was 197,967 tonnes, with revenue of US$202 million. The company plans a three-stage expansion, with initial capital expenditure of US$271 million. FY27 production guidance is 198,000 to 210,000 tonnes.

$CVXMedAI 8/10

Chevron (CVX) Doubles Down on Venezuela with a $7 Billion Oil Bet

Chevron (CVX) plans to invest $7 billion in Venezuela over five years to double oil production to 600,000 barrels per day, adding areas in the Orinoco Belt to its joint venture with PDVSA. The move leverages Chevron's existing presence and aims for low-cost growth, despite political and regulatory risks. Venezuela holds the world's largest crude oil reserves but faces infrastructure challenges.